News
PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...
18h
Gulf Business on MSNMubadala announces reinvestment in PCI Pharma Services
The new investment will support both organic and inorganic expansion, including growth in sterile fill-finish injectables, ...
PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...
More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...
A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.
PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.
Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.
Weekly companies-for-sale update, featuring two newly announced deals in fire safety and drug development; KKR announces ...
Mubadala Investment Company (Mubadala), announced the official commencement of the Al Maryah Waterfront enhancement project, ...
Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).
1d
MyChesCo on MSNBain Capital Joins Kohlberg and Mubadala in Strategic Investment to Accelerate Growth of PCI Pharma Services
PCI Pharma Services has secured a new round of strategic investment, with Bain Capital joining existing lead investor Kohlberg and reinvestment partner Mubadala Investment Company to support ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results